• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Weekly, September 06, 2016

The CenterWatch Weekly, September 06, 2016

September 6, 2016
CenterWatch Staff

DCRI, Boehringer expand patient registry

Boehringer Ingelheim Pharmaceuticals and the Duke Clinical Research Institute (DCRI) are markedly expanding the reach of the Idiopathic Pulmonary Fibrosis– PROspective Outcomes (IPF-PRO) Registry, the first multicenter longitudinal patient registry for IPF in the U.S. IPF-PRO patient registries can be critical to the understanding and study of unusual diseases, and the development of these registries is on the rise. First launched in 2014 with a goal of enrolling 300 patients at 18 clinical study sites, the registry now aims to increase enrollment to 1,500 patients across 45 sites nationwide.

Biomedical Systems and Foundry Health partner on immediate-access data system

Biomedical Systems and Foundry Health are partnering to create a cloud-based data management system that delivers clinical trial data in real time. Industry experts believe that cloud-based data management systems for clinical trials offer the potential of greater speed and flexibility, which could reduce costs, increase collaboration between researchers and accelerate the research and development process. The delivery of immediately accessible data could allow researchers to advance trials more quickly—or even address potential problems as soon as they appear.

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing